71 results
Page 3 of 4
6-K
EX-99.1
8rb9 h7rxhc
19 Feb 21
Pipeline and capital for growth
6:00am
6-K
EX-99.1
3tneozwzc1987tu9
3 Dec 20
Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
4:34pm
6-K
EX-99.1
gwcvisdjyio glc
10 Nov 20
Current report (foreign)
6:05am
6-K
EX-99.1
yl1crlqpg3b
30 Sep 20
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
6:00am
6-K
EX-99.1
5lj luvj6uxx
26 Aug 20
Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress
6:37am
6-K
EX-99.2
n90g6g3941
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
ldfof2
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.2
biy1h
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
7c9gx
13 Jan 20
Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis
6:06am
6-K
EX-99.1
1b7q4knbyg
9 Dec 19
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
10:11am
6-K
EX-99.1
v79c53
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.2
ate3sq7v65r4xw
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99
kka2r10jylwz lihlx
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99
dh03wcb70kndx d7b1
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.1
sacpf
11 Jun 19
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
6:05am
6-K
EX-99.2
9sp687klrxq1b
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm
6-K
EX-99.1
yr193zsp
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm
6-K
EX-99.1
bsr1y 87sq
24 Apr 19
Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
6:01am